Seaport Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 21, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $225,000,000
Company Info
- Founding Year
- 2024
- Traction
- Seaport has raised a total of $325 million since its launch in April 2024.
- Founders
- PureTech Health
- Company Description
- Seaport Therapeutics is a biotechnology company focused on developing innovative drugs for the brain, aiming to create psychiatric medicines that last longer and have fewer side effects. Founded by PureTech Health, the company is advancing its pipeline with a focus on enhancing the delivery of allopregnanolone to the brain.
- Market
- Pharmaceuticals
- Location
- Boston, Massachusetts, USA